Report

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 39
1.3.2 INCLUSIONS AND EXCLUSIONS 40
1.3.3 YEARS CONSIDERED 40
1.4 CURRENCY CONSIDERED 40
1.5 STAKEHOLDERS 41
1.6 SUMMARY OF CHANGES 41
1.7 IMPACT OF AI/GEN AI 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH APPROACH 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 44
2.1.2 PRIMARY DATA 44
2.1.2.1 Key data from primary sources 45
2.1.2.2 Insights from primary experts 46
2.2 RESEARCH METHODOLOGY DESIGN 47
2.3 MARKET SIZE ESTIMATION METHODOLOGY 48
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 54
2.5 RESEARCH ASSUMPTIONS 55
2.6 RESEARCH LIMITATIONS 55
2.6.1 METHODOLOGY-RELATED LIMITATIONS 55
2.6.2 SCOPE-RELATED LIMITATIONS 56
2.7 RISK ASSESSMENT 56
3 EXECUTIVE SUMMARY 57
4 PREMIUM INSIGHTS 61
4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW 61
4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023) 62
4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY 63
4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX 63
4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS.
DEVELOPED COUNTRIES 64
?
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
5.2.1 DRIVERS 66
5.2.1.1 Favorable government initiatives for electronic health record adoption 66
5.2.1.2 Growing venture capital investments in startups 67
5.2.1.3 Need to reduce healthcare costs 68
5.2.1.4 Increasing focus on real-world evidence 69
5.2.1.5 Rise of telemedicine and remote patient monitoring 69
5.2.1.6 Growing focus on regulatory compliance 70
5.2.2 RESTRAINTS 70
5.2.2.1 High cost of analytics solutions 70
5.2.2.2 Growing concerns about data breach 70
5.2.3 OPPORTUNITIES 73
5.2.3.1 Increasing focus on value-based medicines 73
5.2.3.2 Growing use of analytics in healthcare 74
5.2.3.3 Rising number of patient registries 75
5.2.3.4 Emergence of social media and digital health technologies 75
5.2.4 CHALLENGES 75
5.2.4.1 Concerns regarding inaccurate and inconsistent data 75
5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries 76
5.2.4.3 Lack of maintenance of medical records 76
5.2.4.4 Shortage of skilled personnel 76
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 77
5.4 INDUSTRY TRENDS 78
5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS
AMONG MARKET PLAYERS 78
5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS 78
5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS 79
5.5 ECOSYSTEM ANALYSIS 80
5.6 VALUE CHAIN ANALYSIS 82
5.7 TECHNOLOGY ANALYSIS 83
5.7.1 KEY TECHNOLOGIES 83
5.7.1.1 Big data analytics 83
5.7.1.2 Artificial intelligence and machine learning 84
5.7.1.3 Business intelligence tools 84
5.7.2 ADJACENT TECHNOLOGIES 85
5.7.2.1 Cloud computing 85
5.7.2.2 Internet of things 85
?
5.8 REGULATORY ANALYSIS 86
5.8.1 REGULATORY LANDSCAPE 86
5.8.2 GOVERNMENT REGULATIONS 89
5.8.2.1 US 89
5.8.2.2 Europe 89
5.8.2.3 China 89
5.8.2.4 Japan 89
5.8.2.5 India 90
5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
5.9 PRICING ANALYSIS 92
5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS,
BY COMPONENT 93
5.9.2 AVERAGE SELLING PRICE, BY REGION 93
5.10 PORTER'S FIVE FORCES ANALYSIS 94
5.11 PATENT ANALYSIS 96
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 99
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
5.12.2 BUYING CRITERIA 100
5.13 END-USER ANALYSIS 101
5.13.1 UNMET NEEDS 101
5.13.2 END-USER EXPECTATIONS 102
5.14 KEY CONFERENCES AND EVENTS, 2024-2025 103
5.15 CASE STUDY ANALYSIS 104
5.16 BUSINESS MODEL ANALYSIS 107
5.17 INVESTMENT AND FUNDING SCENARIO 108
5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET 109
5.18.1 KEY USE CASES 110
5.18.2 CASE STUDY ON AI/GEN AI 110
5.18.3 ADJACENT MARKET ECOSYSTEM 111
5.18.3.1 Life science analytics market 111
5.18.3.2 Healthcare IT market 112
5.18.3.3 Healthcare fraud analytics market 112
5.18.4 USER READINESS AND IMPACT ASSESSMENT 112
5.18.4.1 User readiness 112
5.18.4.1.1 Payers 112
5.18.4.1.2 Providers 112
5.18.4.2 Impact assessment 113
5.18.4.2.1 User A: Payers 113
5.18.4.2.1.1 Implementation 113
5.18.4.2.1.2 Impact 113
5.18.4.2.2 User B: Providers 113
5.18.4.2.2.1 Implementation 113
5.18.4.2.2.2 Impact 114
6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT 115
6.1 INTRODUCTION 116
6.2 SERVICES 116
6.2.1 MANAGED SERVICES 118
6.2.1.1 Analytical services 120
6.2.1.1.1 Increasing volume of healthcare data to facilitate growth 120
6.2.1.2 Consulting services 121
6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth 121
6.2.2 PROFESSIONAL SERVICES 122
6.2.2.1 Training & implementation services 124
6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market 124
6.2.2.2 Maintenance & support services 125
6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services 125
6.3 SOFTWARE 126
6.3.1 ON-PREMISE SOFTWARE 128
6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market 128
6.3.2 CLOUD-BASED SOFTWARE 130
6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption 130
7 HEALTHCARE ANALYTICS MARKET, BY TYPE 132
7.1 INTRODUCTION 133
7.2 DESCRIPTIVE ANALYTICS 133
7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET 133
7.3 PREDICTIVE ANALYTICS 135
7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH 135
7.4 PRESCRIPTIVE ANALYTICS 137
7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH 137
7.5 DIAGNOSTIC ANALYTICS 139
7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH 139
?
8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION 141
8.1 INTRODUCTION 142
8.2 FINANCIAL ANALYTICS 142
8.2.1 CLAIMS PROCESSING 144
8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth 144
8.2.2 REVENUE CYCLE MANAGEMENT 146
8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market 146
8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE 147
8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market 147
8.2.4 RISK ADJUSTMENT & ASSESSMENT 149
8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth 149
8.3 CLINICAL ANALYTICS 151
8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING 153
8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market 153
8.3.2 CLINICAL DECISION SUPPORT 154
8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market 154
8.3.3 REPORTING & COMPLIANCE 156
8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth 156
8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS 157
8.3.4.1 Growing adoption of electronic health records to fuel market 157
8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE 158
8.3.5.1 Strong government support for personalized medicine to sustain growth 158
8.3.6 MEDICAL IMAGING ANALYTICS 160
8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth 160
8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 161
8.4.1 SUPPLY CHAIN ANALYTICS 163
8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market 163
8.4.2 WORKFORCE ANALYTICS 165
8.4.2.1 Need for effective recruitment to favor growth 165
8.4.3 STRATEGIC ANALYTICS 166
8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market 166
8.5 POPULATION HEALTH ANALYTICS 167
8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH 167
9 HEALTHCARE ANALYTICS MARKET, BY END USER 169
9.1 INTRODUCTION 170
9.2 PAYERS 170
9.2.1 PRIVATE INSURANCE COMPANIES 172
9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth 172
9.2.2 GOVERNMENT AGENCIES 173
9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market 173
9.3 PROVIDERS 174
9.3.1 HOSPITALS & CLINICS 176
9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market 176
9.3.2 POST-ACUTE CARE ORGANIZATIONS 177
9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market 177
9.3.3 AMBULATORY SURGERY CENTERS 178
9.3.3.1 Need to control healthcare costs to support market 178
9.3.4 OTHER PROVIDERS 180
9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN 182
9.4.1 MANUFACTURERS 183
9.4.1.1 Growing adoption of digital technologies to drive market 183
9.4.2 DISTRIBUTORS & WHOLESALERS 185
9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market 185
9.4.3 RETAILERS 186
9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth 186
10 HEALTHCARE ANALYTICS MARKET, BY REGION 187
10.1 INTRODUCTION 188
10.2 NORTH AMERICA 189
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 189
10.2.2 US 196
10.2.2.1 High adoption of electronic health records to drive market 196
10.2.3 CANADA 202
10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market 202
10.3 EUROPE 208
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 208
10.3.2 GERMANY 214
10.3.2.1 Government initiatives to increase use of analytics in healthcare 214
10.3.3 UK 220
10.3.3.1 Availability of venture capital investments to drive market 220
10.3.4 FRANCE 225
10.3.4.1 Strong financial support for digital health to augment market 225
10.3.5 ITALY 231
10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 231
10.3.6 SPAIN 236
10.3.6.1 Growing adoption of personalized medicine to drive market 236
10.3.7 REST OF EUROPE 241
10.4 ASIA PACIFIC 246
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 247
10.4.2 JAPAN 254
10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions 254
10.4.3 CHINA 259
10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth 259
10.4.4 INDIA 264
10.4.4.1 Favorable government initiatives to fuel market 264
10.4.5 REST OF ASIA PACIFIC 270
10.5 LATIN AMERICA 275
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 276
10.5.2 BRAZIL 282
10.5.2.1 Growing adoption of digital solutions in healthcare to boost market 282
10.5.3 MEXICO 288
10.5.3.1 Growing prominence of startups and rising R&D activity to propel market 288
10.5.4 REST OF LATIN AMERICA 293
10.6 MIDDLE EAST & AFRICA 298
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 299
10.6.2 GCC COUNTRIES 305
10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market 305
10.6.3 REST OF MIDDLE EAST & AFRICA 311
11 COMPETITIVE LANDSCAPE 317
11.1 INTRODUCTION 317
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025 317
11.3 REVENUE ANALYSIS, 2019-2023 319
11.4 MARKET SHARE ANALYSIS, 2023 320
11.5 COMPANY EVALUATION AND FINANCIAL METRICS 322
11.6 BRAND/SOFTWARE COMPARISON 323
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 324
?
11.7.1 STARS 324
11.7.2 EMERGING LEADERS 324
11.7.3 PERVASIVE PLAYERS 324
11.7.4 PARTICIPANTS 324
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 326
11.7.5.1 Company footprint 326
11.7.5.2 Region footprint 327
11.7.5.3 Component footprint 328
11.7.5.4 Application footprint 329
11.7.5.5 End-user footprint 330
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 331
11.8.1 PROGRESSIVE COMPANIES 331
11.8.2 RESPONSIVE COMPANIES 331
11.8.3 DYNAMIC COMPANIES 331
11.8.4 STARTING BLOCKS 331
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 333
11.8.5.1 Detailed list of key startups/SMEs 333
11.8.5.2 Competitive benchmarking of key startups/SMEs 334
11.9 COMPETITIVE SCENARIO 335
11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES 335
11.9.2 DEALS 336
11.9.3 EXPANSIONS 337
12 COMPANY PROFILES 338
12.1 KEY PLAYERS 338
12.1.1 MERATIVE 338
12.1.1.1 Business overview 338
12.1.1.2 Products/Solutions/Services offered 339
12.1.1.3 Recent developments 339
12.1.1.3.1 Product/Solution launches/enhancements/approvals/ upgrades 339
12.1.1.3.2 Deals 340
12.1.1.4 MnM view 340
12.1.1.4.1 Key strengths 340
12.1.1.4.2 Strategic choices 340
12.1.1.4.3 Weaknesses and competitive threats 340
12.1.2 SAS INSTITUTE INC. 341
12.1.2.1 Business overview 341
12.1.2.2 Products/Solutions/Services offered 341
12.1.2.3 Recent developments 342
12.1.2.3.1 Product/Solution launches/enhancements/approvals/ upgrades 342
12.1.2.4 MnM view 343
12.1.2.4.1 Key strengths 343
12.1.2.4.2 Strategic choices 343
12.1.2.4.3 Weaknesses and competitive threats 343
12.1.3 OPTUM, INC. 344
12.1.3.1 Business overview 344
12.1.3.2 Products/Solutions/Services offered 345
12.1.3.3 Recent developments 346
12.1.3.3.1 Deals 346
12.1.3.4 MnM view 347
12.1.3.4.1 Key strengths 347
12.1.3.4.2 Strategic choices 347
12.1.3.4.3 Weaknesses and competitive threats 347
12.1.4 ORACLE 348
12.1.4.1 Business overview 348
12.1.4.2 Products/Solutions/Services offered 349
12.1.4.3 Recent developments 350
12.1.4.3.1 Product/Solution launches/enhancements/approvals/ upgrades 350
12.1.4.3.2 Deals 351
12.1.4.3.3 Expansions 352
12.1.4.4 MnM view 352
12.1.4.4.1 Key strengths 352
12.1.4.4.2 Strategic choices 352
12.1.4.4.3 Weaknesses and competitive threats 352
12.1.5 VERADIGM LLC 353
12.1.5.1 Business overview 353
12.1.5.2 Products/Solutions/Services offered 354
12.1.5.3 Recent developments 355
12.1.5.3.1 Product/Solution launches/enhancements/approvals/ upgrades 355
12.1.5.3.2 Deals 355
12.1.5.3.3 Expansions 357
12.1.5.3.4 Other developments 357
12.1.5.4 MnM view 357
12.1.5.4.1 Key strengths 357
12.1.5.4.2 Strategic choices 357
12.1.5.4.3 Weaknesses and competitive threats 358
12.1.6 EXLSERVICE HOLDINGS, INC. 359
12.1.6.1 Business overview 359
12.1.6.2 Products/Solutions/Services offered 360
12.1.6.3 Recent developments 361
12.1.6.3.1 Product/Solution launches/enhancements/approvals/ upgrades 361
12.1.6.3.2 Deals 361
12.1.6.3.3 Other developments 362
12.1.7 CITIUSTECH INC. 363
12.1.7.1 Business overview 363
12.1.7.2 Products/Solutions/Services offered 363
12.1.7.3 Recent developments 364
12.1.7.3.1 Product/Solution launches/enhancements/approvals/ upgrades 364
12.1.7.3.2 Deals 365
12.1.7.3.3 Expansions 365
12.1.7.3.4 Other developments 365
12.1.8 HEALTH CATALYST 366
12.1.8.1 Business overview 366
12.1.8.2 Products/Solutions/Services offered 367
12.1.8.3 Recent developments 368
12.1.8.3.1 Product/Solution launches/enhancements/approvals/ upgrades 368
12.1.8.3.2 Deals 368
12.1.9 CVS HEALTH 370
12.1.9.1 Business overview 370
12.1.9.2 Products/Solutions/Services offered 371
12.1.9.3 Recent developments 371
12.1.9.3.1 Deals 371
12.1.10 INOVALON 372
12.1.10.1 Business overview 372
12.1.10.2 Products/Solutions/Services offered 372
12.1.10.3 Recent developments 373
12.1.10.3.1 Product/Solution launches/enhancements/approvals/ upgrades 373
12.1.10.3.2 Deals 374
12.1.10.3.3 Expansions 374
12.1.10.3.4 Other developments 375
12.1.11 MCKESSON CORPORATION 376
12.1.11.1 Business overview 376
12.1.11.2 Products/Solutions/Services offered 377
12.1.11.3 Recent developments 378
12.1.11.3.1 Deals 378
12.1.12 MEDEANALYTICS, INC. 379
12.1.12.1 Business overview 379
12.1.12.2 Products/Solutions/Services offered 379
12.1.12.3 Recent developments 380
12.1.12.3.1 Deals 380
12.1.12.3.2 Other developments 380
12.1.13 COTIVITI, INC. 381
12.1.13.1 Business overview 381
12.1.13.2 Products/Solutions/Services offered 381
12.1.13.3 Recent developments 382
12.1.13.3.1 Product/Solution launches/enhancements/approvals/ upgrades 382
12.1.13.3.2 Other developments 382
12.1.14 APIXIO, INC. 383
12.1.14.1 Business overview 383
12.1.14.2 Products/Solutions/Services offered 383
12.1.14.3 Recent developments 384
12.1.14.3.1 Product/Solution launches/enhancements/approvals/ upgrades 384
12.1.14.3.2 Deals 385
12.1.15 ENLITIC 386
12.1.15.1 Business overview 386
12.1.15.2 Products/Solutions/Services offered 386
12.1.15.3 Recent developments 387
12.1.15.3.1 Product/Solution launches/enhancements/approvals/ upgrades 387
12.1.15.3.2 Deals 388
12.1.16 KOMODO HEALTH, INC. 389
12.1.16.1 Business overview 389
12.1.16.2 Products/Solutions/Services offered 389
12.1.16.3 Recent developments 390
12.1.16.3.1 Product/Solution launches/enhancements/approvals/ upgrades 390
12.1.16.3.2 Deals 390
12.1.17 HEALTHEC, LLC 392
12.1.17.1 Business overview 392
12.1.17.2 Products/Solutions/Services offered 392
12.1.17.3 Recent developments 392
12.1.17.3.1 Deals 392
12.1.18 IQVIA 393
12.1.18.1 Business overview 393
12.1.18.2 Products/Solutions/Services offered 394
12.1.18.3 Recent developments 395
12.1.18.3.1 Deals 395
12.1.19 WIPRO 396
12.1.19.1 Business overview 396
12.1.19.2 Products/Solutions/Services offered 398
12.2 OTHER PLAYERS 399
12.2.1 ARCADIA SOLUTIONS, LLC. 399
12.2.2 EVIDATION HEALTH, INC. 399
12.2.3 HEALTHCORUM 400
12.2.4 AETION, INC. 400
12.2.5 TREDENCE.INC. 401
12.2.6 SISENSE LTD. 401
13 APPENDIX 402
13.1 DISCUSSION GUIDE 402
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 407
13.3 CUSTOMIZATION OPTIONS 409
13.4 RELATED REPORTS 409
13.5 AUTHOR DETAILS 410

TABLE 1 HEALTHCARE ANALYTICS MARKET: INCLUSIONS AND EXCLUSIONS 40
TABLE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH ASSUMPTIONS 55
TABLE 3 HEALTHCARE ANALYTICS MARKET: RISK ASSESSMENT 56
TABLE 4 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023-2024 73
TABLE 5 HEALTHCARE ANALYTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 80
TABLE 6 NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 86
TABLE 7 EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 87
TABLE 8 ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 87
TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE
ANALYTICS MARKET 88
TABLE 10 LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET 89
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 92
TABLE 16 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS,
BY COMPONENT 93
TABLE 17 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION 94
TABLE 18 HEALTHCARE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS 95
TABLE 19 HEALTHCARE ANALYTICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2024 98
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE END USERS (%) 99
TABLE 21 KEY BUYING CRITERIA FOR END USERS 100
TABLE 22 UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET 101
TABLE 23 END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET 102
TABLE 24 HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2024-2025 103
TABLE 25 ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS 104
TABLE 26 USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT 105
TABLE 27 ENHANCED CLINICAL DECISION-MAKING PROCESS WITH DATA OPERATING SYSTEM PLATFORM 106
TABLE 28 ENHANCED PATIENT OUTCOMES WITH AI-DRIVEN PREDICTIVE ANALYTICS 110
TABLE 29 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 116
TABLE 30 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 117
TABLE 31 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION,
2022-2029 (USD MILLION) 118
TABLE 32 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,
2022-2029 (USD MILLION) 119
TABLE 33 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION,
2022-2029 (USD MILLION) 119
TABLE 34 HEALTHCARE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY REGION,
2022-2029 (USD MILLION) 121
TABLE 35 HEALTHCARE ANALYTICS MARKET FOR CONSULTING SERVICES, BY REGION, 2022-2029 (USD MILLION) 122
TABLE 36 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE,
2022-2029 (USD MILLION) 123
TABLE 37 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2022-2029 (USD MILLION) 124
TABLE 38 HEALTHCARE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY REGION, 2022-2029 (USD MILLION) 125
TABLE 39 HEALTHCARE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES,
BY REGION, 2022-2029 (USD MILLION) 126
TABLE 40 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 127
TABLE 41 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION,
2022-2029 (USD MILLION) 128
TABLE 42 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022-2029 (USD MILLION) 129
TABLE 43 HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022-2029 (USD MILLION) 131
TABLE 44 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 133
TABLE 45 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 134
TABLE 46 APPLICATIONS OF PREDICTIVE ANALYTICS 135
TABLE 47 COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS 136
TABLE 48 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 137
TABLE 49 COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS 138
TABLE 50 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 138
TABLE 51 DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 140
TABLE 52 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 142
TABLE 53 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS 143
TABLE 54 FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 143
TABLE 55 FINANCIAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 144
TABLE 56 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS 145
TABLE 57 FINANCIAL ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION,
2022-2029 (USD MILLION) 145
TABLE 58 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS 146
TABLE 59 FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2022-2029 (USD MILLION) 147
TABLE 60 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS 148
TABLE 61 FINANCIAL ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2022-2029 (USD MILLION) 149
TABLE 62 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS 150
TABLE 63 FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT,
BY REGION, 2022-2029 (USD MILLION) 150
TABLE 64 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS 151
TABLE 65 CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 152
TABLE 66 CLINICAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 152
TABLE 67 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT &
CLINICAL BENCHMARKING SOLUTIONS 153
TABLE 68 CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2022-2029 (USD MILLION) 154
TABLE 69 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT 155
TABLE 70 CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2022-2029 (USD MILLION) 155
TABLE 71 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE 156
TABLE 72 CLINICAL ANALYTICS MARKET FOR REPORTING & COMPLIANCE, BY REGION, 2022-2029 (USD MILLION) 157
TABLE 73 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS 157
TABLE 74 CLINICAL ANALYTICS MARKET FOR COMPARATIVE ANALYTICS/EFFECTIVENESS,
BY REGION, 2022-2029 (USD MILLION) 158
TABLE 75 COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD
EVIDENCE SOLUTIONS 159
TABLE 76 CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH/REAL-WORLD EVIDENCE, BY REGION, 2022-2029 (USD MILLION) 159
TABLE 77 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS 160
TABLE 78 CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2022-2029 (USD MILLION) 161
TABLE 79 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS 162
TABLE 80 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 162
TABLE 81 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION,
2022-2029 (USD MILLION) 163
TABLE 82 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS 164
TABLE 83 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2022-2029 (USD MILLION) 164
TABLE 84 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS 165
TABLE 85 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2022-2029 (USD MILLION) 166
TABLE 86 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2022-2029 (USD MILLION) 167
TABLE 87 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS 168
TABLE 88 POPULATION HEALTH ANALYTICS MARKET, BY REGION,
2022-2029 (USD MILLION) 168
TABLE 89 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 170
TABLE 90 COMMERCIALLY AVAILABLE SOLUTIONS FOR HEALTHCARE PAYERS 170
TABLE 91 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 171
TABLE 92 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION,
2022-2029 (USD MILLION) 171
TABLE 93 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES,
BY REGION, 2022-2029 (USD MILLION) 172
TABLE 94 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2022-2029 (USD MILLION) 173
TABLE 95 COMMERCIALLY AVAILABLE ANALYTICS SOLUTIONS FOR HEALTHCARE PROVIDERS 174
TABLE 96 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2022-2029 (USD MILLION) 175
TABLE 97 HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022-2029 (USD MILLION) 175
TABLE 98 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR HOSPITALS & CLINICS 176
TABLE 99 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & CLINICS, BY REGION,
2022-2029 (USD MILLION) 177
TABLE 100 HEALTHCARE ANALYTICS MARKET FOR POST-ACUTE CARE ORGANIZATIONS,
BY REGION, 2022-2029 (USD MILLION) 178
TABLE 101 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR AMBULATORY SURGERY CENTERS 179
TABLE 102 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2022-2029 (USD MILLION) 179
TABLE 103 COMMERCIALLY AVAILABLE SOLUTIONS FOR ACCOUNTABLE CARE ORGANIZATIONS 180
TABLE 104 HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION,
2022-2029 (USD MILLION) 181
TABLE 105 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 106 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY REGION, 2022-2029 (USD MILLION) 183
TABLE 107 HEALTHCARE ANALYTICS MARKET FOR MANUFACTURERS, BY REGION,
2022-2029 (USD MILLION) 184
TABLE 108 HEALTHCARE ANALYTICS MARKET FOR DISTRIBUTORS & WHOLESALERS,
BY REGION, 2022-2029 (USD MILLION) 185
TABLE 109 HEALTHCARE ANALYTICS MARKET FOR RETAILERS, BY REGION,
2022-2029 (USD MILLION) 186
TABLE 110 HEALTHCARE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION) 188
TABLE 111 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 190
TABLE 112 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 191
TABLE 113 NORTH AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 191
TABLE 114 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 115 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 192
TABLE 116 NORTH AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 192
TABLE 117 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 192
TABLE 118 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 193
TABLE 119 NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 193
TABLE 120 NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 194
TABLE 121 NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 122 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 195
TABLE 123 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 195
TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 126 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 197
TABLE 127 US: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 197
TABLE 128 US: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,
2022-2029 (USD MILLION) 198
TABLE 129 US: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 130 US: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 198
TABLE 131 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 132 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 199
TABLE 133 US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 134 US: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 200
TABLE 135 US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 200
TABLE 136 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 201
TABLE 137 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 201
TABLE 138 US: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 139 US: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 140 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 203
TABLE 141 CANADA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 203
TABLE 142 CANADA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 143 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 144 CANADA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 204
TABLE 145 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 146 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 205
TABLE 147 CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 148 CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 149 CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 206
TABLE 150 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 206
TABLE 151 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 207
TABLE 152 CANADA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 153 CANADA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 154 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 209
TABLE 155 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 209
TABLE 156 EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 210
TABLE 157 EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 210
TABLE 158 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 210
TABLE 159 EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 211
TABLE 160 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 161 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 211
TABLE 162 EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 163 EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 164 EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 213
TABLE 165 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 213
TABLE 166 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 213
TABLE 167 EUROPE: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 168 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL &
MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 169 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 215
TABLE 170 GERMANY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 215
TABLE 171 GERMANY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 172 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 173 GERMANY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 216
TABLE 174 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 217
TABLE 175 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 217
TABLE 176 GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 177 GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 178 GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 179 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 218
TABLE 180 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 219
TABLE 181 GERMANY: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 182 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL &
MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 183 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 220
TABLE 184 UK: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 221
TABLE 185 UK: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE,
2022-2029 (USD MILLION) 221
TABLE 186 UK: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 187 UK: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 222
TABLE 188 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 189 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 222
TABLE 190 UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 191 UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 192 UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 224
TABLE 193 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION) 224
TABLE 194 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 224
TABLE 195 UK: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 196 UK: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 197 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 226
TABLE 198 FRANCE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 226
TABLE 199 FRANCE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 200 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 201 FRANCE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 227
TABLE 202 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 203 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 228
TABLE 204 FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 205 FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 206 FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 229
TABLE 207 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 229
TABLE 208 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 230
TABLE 209 FRANCE: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 210 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 230
TABLE 211 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 231
TABLE 212 ITALY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 231
TABLE 213 ITALY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 214 ITALY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 215 ITALY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 232
TABLE 216 ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 217 ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 233
TABLE 218 ITALY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 219 ITALY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 220 ITALY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 234
TABLE 221 ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 234
TABLE 222 ITALY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 235
TABLE 223 ITALY: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 224 ITALY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 235
TABLE 225 SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 236
TABLE 226 SPAIN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 236
TABLE 227 SPAIN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 228 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 229 SPAIN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 237
TABLE 230 SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 231 SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 238
TABLE 232 SPAIN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 238
TABLE 233 SPAIN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 234 SPAIN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 239
TABLE 235 SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 239
TABLE 236 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 240
TABLE 237 SPAIN: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 238 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 239 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 241
TABLE 240 REST OF EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 241
TABLE 241 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 242 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 243 REST OF EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 242
TABLE 244 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 243
TABLE 245 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 243
TABLE 246 REST OF EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 243
TABLE 247 REST OF EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 244
TABLE 248 REST OF EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 244
TABLE 249 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 245
TABLE 250 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 251 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 252 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 253 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 249
TABLE 254 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 249
TABLE 255 ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 249
TABLE 256 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 250
TABLE 257 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 250
TABLE 258 ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 250
TABLE 259 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 251
TABLE 260 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 251
TABLE 261 ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 251
TABLE 262 ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 263 ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 252
TABLE 264 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 252
TABLE 265 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 253
TABLE 266 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 253
TABLE 267 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 253
TABLE 268 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 254
TABLE 269 JAPAN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 254
TABLE 270 JAPAN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 271 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 255
TABLE 272 JAPAN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 255
TABLE 273 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 274 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 256
TABLE 275 JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 256
TABLE 276 JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 257
TABLE 277 JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 257
TABLE 278 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 257
TABLE 279 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 258
TABLE 280 JAPAN: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 281 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 258
TABLE 282 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 259
TABLE 283 CHINA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 260
TABLE 284 CHINA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 260
TABLE 285 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 260
TABLE 286 CHINA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 261
TABLE 287 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 261
TABLE 288 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 261
TABLE 289 CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 262
TABLE 290 CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 262
TABLE 291 CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 262
TABLE 292 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 263
TABLE 293 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 263
TABLE 294 CHINA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 263
TABLE 295 CHINA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 264
TABLE 296 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 265
TABLE 297 INDIA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 265
TABLE 298 INDIA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 265
TABLE 299 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 300 INDIA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 266
TABLE 301 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 266
TABLE 302 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 267
TABLE 303 INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 267
TABLE 304 INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 268
TABLE 305 INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 268
TABLE 306 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 268
TABLE 307 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 269
TABLE 308 INDIA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 269
TABLE 309 INDIA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 269

TABLE 310 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 270
TABLE 311 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 312 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 313 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 271
TABLE 314 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 272
TABLE 315 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 272
TABLE 316 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 272
TABLE 317 REST OF ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 273
TABLE 318 REST OF ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 273
TABLE 319 REST OF ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 274
TABLE 320 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 274
TABLE 321 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS,
BY TYPE, 2022-2029 (USD MILLION) 274
TABLE 322 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 275
TABLE 323 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 275
TABLE 324 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 276
TABLE 325 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 277
TABLE 326 LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 277
TABLE 327 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 277
TABLE 328 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 278
TABLE 329 LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 278
TABLE 330 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 278
TABLE 331 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 279
TABLE 332 LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 279
TABLE 333 LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 280
TABLE 334 LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 280
TABLE 335 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 281
TABLE 336 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 281
TABLE 337 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 281
TABLE 338 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 282
TABLE 339 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 283
TABLE 340 BRAZIL: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 283
TABLE 341 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 284
TABLE 342 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 284
TABLE 343 BRAZIL: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 284
TABLE 344 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 345 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 285
TABLE 346 BRAZIL: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 285
TABLE 347 BRAZIL: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 286
TABLE 348 BRAZIL: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 286
TABLE 349 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 286
TABLE 350 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 287
TABLE 351 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 352 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 287
TABLE 353 MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 288
TABLE 354 MEXICO: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 288
TABLE 355 MEXICO: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 289
TABLE 356 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 289
TABLE 357 MEXICO: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 289
TABLE 358 MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 290
TABLE 359 MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 290
TABLE 360 MEXICO: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 290
TABLE 361 MEXICO: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 291
TABLE 362 MEXICO: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 291
TABLE 363 MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 291
TABLE 364 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 292
TABLE 365 MEXICO: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 366 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL &
MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 292
TABLE 367 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 293
TABLE 368 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET,
BY TYPE, 2022-2029 (USD MILLION) 293
TABLE 369 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 294
TABLE 370 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 294
TABLE 371 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 294
TABLE 372 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 295
TABLE 373 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 295
TABLE 374 REST OF LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 296
TABLE 375 REST OF LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 296
TABLE 376 REST OF LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 297
TABLE 377 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 297
TABLE 378 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION) 297
TABLE 379 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 298
TABLE 380 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE,
2022-2029 (USD MILLION) 298
TABLE 381 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 299
TABLE 382 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 300
TABLE 383 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION) 300
TABLE 384 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 300
TABLE 385 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 301
TABLE 386 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 301
TABLE 387 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 301
TABLE 388 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 302
TABLE 389 MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 302
TABLE 390 MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 303
TABLE 391 MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 303
TABLE 392 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 304
TABLE 393 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION) 304
TABLE 394 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 304
TABLE 395 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 305
TABLE 396 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT,
2022-2029 (USD MILLION) 306
TABLE 397 GCC COUNTRIES: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 306
TABLE 398 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES,
BY TYPE, 2022-2029 (USD MILLION) 306
TABLE 399 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 307
TABLE 400 GCC COUNTRIES: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE,
2022-2029 (USD MILLION) 307
TABLE 401 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 307
TABLE 402 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION,
2022-2029 (USD MILLION) 308
TABLE 403 GCC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 308
TABLE 404 GCC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 309
TABLE 405 GCC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 309
TABLE 406 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER,
2022-2029 (USD MILLION) 310
TABLE 407 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE,
2022-2029 (USD MILLION) 310
TABLE 408 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 310
TABLE 409 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION) 311
TABLE 410 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION) 311
TABLE 411 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET,
BY TYPE, 2022-2029 (USD MILLION) 312
TABLE 412 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION) 312
TABLE 413 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION) 312
TABLE 414 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION) 313
TABLE 415 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY TYPE, 2022-2029 (USD MILLION) 313
TABLE 416 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY APPLICATION, 2022-2029 (USD MILLION) 313
TABLE 417 REST OF MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 314
TABLE 418 REST OF MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE,
2022-2029 (USD MILLION) 314
TABLE 419 REST OF MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION) 315
TABLE 420 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET,
BY END USER, 2022-2029 (USD MILLION) 315
TABLE 421 REST OF MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION) 315
TABLE 422 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022-2029 (USD MILLION) 316
TABLE 423 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE,
2022-2029 (USD MILLION) 316
TABLE 424 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE
ANALYTICS MARKET, 2021-2025 318
TABLE 425 HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION 320
TABLE 426 HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT 327
TABLE 427 HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT 328
TABLE 428 HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT 329
TABLE 429 HEALTHCARE ANALYTICS MARKET: END-USER FOOTPRINT 330
TABLE 430 HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES 333
TABLE 431 HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 334
TABLE 432 HEALTHCARE ANALYTICS MARKET: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,
JANUARY 2021-JANUARY 2025 335
TABLE 433 HEALTHCARE ANALYTICS MARKET: DEALS, JANUARY 2021-JANUARY 2025 336
TABLE 434 HEALTHCARE ANALYTICS MARKET: EXPANSIONS, JANUARY 2021-JANUARY 2025 337
TABLE 435 MERATIVE: COMPANY OVERVIEW 338
TABLE 436 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 339
TABLE 437 MERATIVE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,
JANUARY 2021-JANUARY 2025 339
TABLE 438 MERATIVE: DEALS, JANUARY 2021-JANUARY 2025 340
TABLE 439 SAS INSTITUTE INC.: COMPANY OVERVIEW 341
TABLE 440 SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 341
TABLE 441 SAS INSTITUTE INC.: PRODUCT/SOLUTION LAUNCHES/ ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025 342
TABLE 442 OPTUM, INC.: COMPANY OVERVIEW 344
TABLE 443 OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 345
TABLE 444 OPTUM, INC.: DEALS, JANUARY 2021-JANUARY 2025 346
TABLE 445 ORACLE: COMPANY OVERVIEW 348
TABLE 446 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 349
TABLE 447 ORACLE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,
JANUARY 2021-JANUARY 2025 350
TABLE 448 ORACLE: DEALS, JANUARY 2021-JANUARY 2025 351
TABLE 449 ORACLE: EXPANSIONS, JANUARY 2021-JANUARY 2025 352
TABLE 450 VERADIGM LLC: COMPANY OVERVIEW 353
TABLE 451 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 354
TABLE 452 VERADIGM LLC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025 355
TABLE 453 VERADIGM LLC: DEALS, JANUARY 2021-JANUARY 2025 355
TABLE 454 VERADIGM LLC: EXPANSIONS, JANUARY 2021-JANUARY 2025 357
TABLE 455 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 357
TABLE 456 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 359
TABLE 457 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 360
TABLE 458 EXLSERVICE HOLDINGS, INC.: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025 361
TABLE 459 EXLSERVICE HOLDINGS, INC.: DEALS, JANUARY 2021-JANUARY 2025 361
TABLE 460 EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS,
JANUARY 2021-JANUARY 2025 362
TABLE 461 CITIUSTECH INC.: COMPANY OVERVIEW 363
TABLE 462 CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 363
TABLE 463 CITIUSTECH INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025 364
TABLE 464 CITIUSTECH INC.: DEALS, JANUARY 2021-JANUARY 2025 365
TABLE 465 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 365
TABLE 466 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 365
TABLE 467 HEALTH CATALYST: COMPANY OVERVIEW 366
TABLE 468 HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED 367
TABLE 469 HEALTH CATALYST: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES,
JANUARY 2021-JANUARY 2025 368
TABLE 470 HEALTH CATALYST: DEALS, JANUARY 2021-JANUARY 2025 368
TABLE 471 CVS HEALTH: COMPANY OVERVIEW 370
TABLE 472 CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 371
TABLE 473 CVS HEALTH: DEALS, JANUARY 2021-JANUARY 2025 371
TABLE 474 INOVALON: COMPANY OVERVIEW 372
TABLE 475 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 372
TABLE 476 INOVALON: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,
JANUARY 2021-JANUARY 2025 373
TABLE 477 INOVALON: DEALS, JANUARY 2021-JANUARY 2025 374
TABLE 478 INOVALON: EXPANSIONS, JANUARY 2021-JANUARY 2025 374
TABLE 479 INOVALON: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 375
TABLE 480 MCKESSON CORPORATION: COMPANY OVERVIEW 376
TABLE 481 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 377
TABLE 482 MCKESSON CORPORATION: DEALS, JANUARY 2021-JANUARY 2025 378
TABLE 483 MEDEANALYTICS, INC.: COMPANY OVERVIEW 379
TABLE 484 MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 379
TABLE 485 MEDEANALYTICS, INC.: DEALS, JANUARY 2021-JANUARY 2025 380
TABLE 486 MEDEANALYTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 380
TABLE 487 COTIVITI, INC.: COMPANY OVERVIEW 381
TABLE 488 COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 381
TABLE 489 COTIVITI, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025 382
TABLE 490 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 382
TABLE 491 APIXIO, INC.: COMPANY OVERVIEW 383
TABLE 492 APIXIO, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 383
TABLE 493 APIXIO, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-JANUARY 2025 384
TABLE 494 APIXIO, INC.: DEALS, JANUARY 2021-JANUARY 2025 385
TABLE 495 ENLITIC: COMPANY OVERVIEW 386
TABLE 496 ENLITIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 386
TABLE 497 ENLITIC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES,
JANUARY 2021-JANUARY 2025 387
TABLE 498 ENLITIC: DEALS, JANUARY 2021-JANUARY 2025 388
TABLE 499 KOMODO HEALTH, INC.: COMPANY OVERVIEW 389
TABLE 500 KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 389
TABLE 501 KOMODO HEALTH, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-JANUARY 2025 390
TABLE 502 KOMODO HEALTH, INC.: DEALS, JANUARY 2021-JANUARY 2025 390
TABLE 503 HEALTHEC, LLC: COMPANY OVERVIEW 392
TABLE 504 HEALTHEC, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 392
TABLE 505 HEALTHEC, LLC: DEALS, JANUARY 2021-JANUARY 2025 392
TABLE 506 IQVIA: COMPANY OVERVIEW 393
TABLE 507 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 394
TABLE 508 IQVIA: DEALS, JANUARY 2021-JANUARY 2025 395
TABLE 509 WIPRO: COMPANY OVERVIEW 396
TABLE 510 WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 398
TABLE 511 ARCADIA SOLUTIONS, LLC.: COMPANY OVERVIEW 399
TABLE 512 EVIDATION HEALTH, INC.: COMPANY OVERVIEW 399
TABLE 513 HEALTHCORUM: COMPANY OVERVIEW 400
TABLE 514 AETION, INC.: COMPANY OVERVIEW 400
TABLE 515 TREDENCE.INC.: COMPANY OVERVIEW 401
TABLE 516 SISENSE LTD.: COMPANY OVERVIEW 401